011312 Niacinamide 4% / Tazarotene 0.05%
Product Images NDC 72934-2208

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011312 Niacinamide 4% / Tazarotene 0.05% (NDC 72934-2208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E (2 End)

E (2 End)
Side label of 011312 NIACINAMIDE 4% / TAZAROTENE 0.05% topical product by Sincerus Florida, LLC. The white cylindrical container shows directions for use instructing application as directed by a physician, for external use only, with hand washing after use. Manufacturer contact information and storage conditions at controlled room temperature (20-25°C) are also visible, along with a QR code.*
FDA Label Image

D (2208 2 Front)

D (2208 2 Front)
011312 Niacinamide 4% / Tazarotene 0.05% cream in a 30 gm white cylindrical container. Label shows the NDC 72934-2208-2 and is marked as a compounded drug made in the USA. The label includes the Sincerus Florida logo and indicates prescription use only.*
FDA Label Image

A (2208 2 Middle)

A (2208 2 Middle)
011312 NIACINAMIDE 4% / TAZAROTENE 0.05% cream in a white cylindrical container with a label showing the active ingredients niacinamide USP 4% and tazarotene 0.05%, plus inactive ingredients suspensisse cream 95.95%. The label indicates Rx only status and includes manufacturer and lot number details, partially obscured by image angle. The labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.